<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T03:15:56Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7045176" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7045176</identifier>
        <datestamp>2020-02-27</datestamp>
        <setSpec>nihpa</setSpec>
        <setSpec>pmc-open</setSpec>
        <setSpec>manuscript</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-journal-id">9815831</journal-id>
              <journal-id journal-id-type="pubmed-jr-id">22061</journal-id>
              <journal-id journal-id-type="nlm-ta">Genet Med</journal-id>
              <journal-id journal-id-type="iso-abbrev">Genet. Med.</journal-id>
              <journal-title-group>
                <journal-title>Genetics in medicine : official journal of the American College of Medical Genetics</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1098-3600</issn>
              <issn pub-type="epub">1530-0366</issn>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7045176</article-id>
              <article-id pub-id-type="pmcid">PMC7045176</article-id>
              <article-id pub-id-type="pmc-uid">7045176</article-id>
              <article-id pub-id-type="pmid">31249402</article-id>
              <article-id pub-id-type="pmid">31249402</article-id>
              <article-id pub-id-type="doi">10.1038/s41436-019-0593-z</article-id>
              <article-id pub-id-type="manuscript">nihpa1536028</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Chronic Kidney Disease in Propionic Acidemia</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Shchelochkov</surname>
                    <given-names>Oleg A.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Manoli</surname>
                    <given-names>Irini</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sloan</surname>
                    <given-names>Jennifer L.</given-names>
                  </name>
                  <degrees>PhD, MS</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ferry</surname>
                    <given-names>Susan</given-names>
                  </name>
                  <degrees>BSN</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pass</surname>
                    <given-names>Alexandra</given-names>
                  </name>
                  <degrees>BA</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Van Ryzin</surname>
                    <given-names>Carol</given-names>
                  </name>
                  <degrees>MS</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Myles</surname>
                    <given-names>Jennifer</given-names>
                  </name>
                  <degrees>MS</degrees>
                  <xref ref-type="aff" rid="A2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Schoenfeld</surname>
                    <given-names>Megan</given-names>
                  </name>
                  <degrees>BS</degrees>
                  <xref ref-type="aff" rid="A2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>McGuire</surname>
                    <given-names>Peter</given-names>
                  </name>
                  <degrees>MS, MD</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rosing</surname>
                    <given-names>Douglas R.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="A3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Levin</surname>
                    <given-names>Mark D.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="A3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kopp</surname>
                    <given-names>Jeffrey B.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="A4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Venditti</surname>
                    <given-names>Charles P.</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref rid="CR1" ref-type="corresp">*</xref>
                </contrib>
              </contrib-group>
              <aff id="A1"><label>1</label>National Human Genome Research Institute, National
Institutes of Health, Bethesda, MD.</aff>
              <aff id="A2"><label>2</label>Nutrition Department, Clinical Research Center, National
Institutes of Health, Bethesda, MD.</aff>
              <aff id="A3"><label>3</label>National Heart Lung and Blood Institute, National
Institutes of Health, Bethesda, MD.</aff>
              <aff id="A4"><label>4</label>National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health, Bethesda, MD.</aff>
              <author-notes>
                <corresp id="CR1"><label>*</label>Corresponding author: Charles P. Venditti,
Building 10, Room 7N248A, National Institutes of Health, Bethesda, MD
20892-4472, Office phone: 301-496-6213, FAX: 301-402-4929,
<email>venditti@mail.nih.gov</email></corresp>
              </author-notes>
              <pub-date pub-type="nihms-submitted">
                <day>31</day>
                <month>7</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>28</day>
                <month>6</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <month>12</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>27</day>
                <month>2</month>
                <year>2020</year>
              </pub-date>
              <volume>21</volume>
              <issue>12</issue>
              <fpage>2830</fpage>
              <lpage>2835</lpage>
              <!--elocation-id from pubmed: 10.1038/s41436-019-0593-z-->
              <permissions>
                <license xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">
                  <license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<ext-link ext-link-type="uri" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</ext-link></license-p>
                </license>
              </permissions>
              <abstract id="ABS1">
                <sec id="S1">
                  <title>Purpose</title>
                  <p id="P1">Propionic acidemia (PA) is a severe metabolic disorder characterized
by multiorgan pathology, including renal disease. The prevalence of chronic
kidney disease (CKD) in PA patients and factors associated with CKD in PA
are not known.</p>
                </sec>
                <sec id="S2">
                  <title>Methods</title>
                  <p id="P2">Thirty-one subjects diagnosed with PA underwent laboratory and
clinical evaluations through a dedicated natural history study at the NIH
(<ext-link ext-link-type="uri" xlink:href="https://ClinicalTrials.gov">ClinicalTrials.gov</ext-link> identifier: <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT02890342">NCT02890342</ext-link>).</p>
                </sec>
                <sec id="S3">
                  <title>Results</title>
                  <p id="P3">Cross-sectional analysis of the creatinine-based estimated glomerular
filtration rate (eGFR) in subjects with native kidneys revealed an
age-dependent decline in renal function (P &lt;0.002). Among adults with
PA, 4/8 (50%) had eGFR &lt;60 mL/min/1.73 m<sup>2</sup>. There was a
significant discrepancy between eGFRs calculated using estimating equations
based on serum creatinine compared to serum cystatin C (P &lt;0.0001).
The tubular injury marker, plasma lipocalin-2, and plasma uric acid were
strongly associated with CKD (P &lt;0.0001). The measured 24-hour
creatinine excretion was below normal, even after adjusting for age, height,
and sex.</p>
                </sec>
                <sec id="S4">
                  <title>Conclusions</title>
                  <p id="P4">CKD is common in adults with PA and is associated with age. The poor
predictive performance of standard eGFR estimating equations, likely due to
reduced creatine synthesis in kidney and liver, could delay the recognition
of CKD and management of ensuing complications in this population.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>propionic acidemia</kwd>
                <kwd>chronic kidney disease</kwd>
                <kwd>GFR</kwd>
                <kwd>cystatin C</kwd>
                <kwd>creatinine</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec id="S5">
              <title>Introduction</title>
              <p id="P5">Propionic acidemia (PA) is a metabolic disorder that carries a marked risk
for multiorgan pathology<sup><xref rid="R1" ref-type="bibr">1</xref></sup>. Chronic
kidney disease (CKD, here narrowly defined as the glomerular filtration rate
&lt;60 ml/min/1.73 m<sup>2</sup>) has been recognized with increased frequency
as a complication in patients with organic acidemias, especially methylmalonic
acidemia (MMA), and more recently, in other categorically related disorders such as
PA and glutaric aciduria type I.<sup><xref rid="R2" ref-type="bibr">2</xref>–<xref rid="R7" ref-type="bibr">7</xref></sup> In PA, the
prevalence, natural history, and factors associated with CKD are incompletely
defined.</p>
              <p id="P6">Studies focused on renal function in PA are scant. An association between PA
and CKD was first suggested in 1997 by Lehnert et al.<sup><xref rid="R6" ref-type="bibr">6</xref></sup> Subsequent PA patient case reports of renal
failure in a 45-year old woman with CKD <sup><xref rid="R5" ref-type="bibr">5</xref></sup> and another who presented with stage 3 CKD in the third decade
of life<sup><xref rid="R7" ref-type="bibr">7</xref></sup> have been bolstered by
registry observations suggesting that the risk of developing CKD in PA increases
with age.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> In addition, a recent
retrospective case review study of liver transplantation in PA showed that half of
patients (4/8) were in stage 2 CKD before the procedure, and 100% of patients (4/4)
were in stage 2–3 CKD in the post-transplant period.<sup><xref rid="R8" ref-type="bibr">8</xref></sup> In yet another European series, 2/6 patients
developed kidney dysfunction after receiving a liver transplant when their diet was
liberalized.<sup><xref rid="R9" ref-type="bibr">9</xref></sup> These
clinical observations suggest that CKD is an under-recognized disease-related
complication in PA, especially in adults.</p>
              <p id="P7">Due to the ramifications of a CKD diagnosis for routine monitoring and
long-term management, it is important to define the natural history of renal
involvement in PA especially because traditional markers of kidney disease, such as
increases in blood urea and serum creatinine, may be obscured by the ingestion of a
low protein diet and decreased muscle mass, both of which are common in the PA
patient population. We have therefore studied a large and genetically heterogenous
cohort of PA patients enrolled in a natural history protocol to approximate the
incidence of CKD and identify risk factors associated with progression. Our
observations provide important new insights into the manifestations of CKD in PA
patients and help establish a framework for the prospective monitoring and the
laboratory assessment of renal complications in this population.</p>
            </sec>
            <sec id="S6">
              <title>Materials and Methods</title>
              <sec id="S7">
                <title>Patient cohort and protocols</title>
                <p id="P8">The diagnosis of PA was confirmed using a combination of biochemical,
clinical and molecular testing before consent and enrollment into a natural
history study (<ext-link ext-link-type="uri" xlink:href="https://ClinicalTrials.gov">ClinicalTrials.gov</ext-link> Identifiers: <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT02890342">NCT02890342</ext-link>). Study protocol was reviewed and approved by the
NIH IRB. All subjects or their legal guardians provided written informed
consent. Thirty-one individuals with PA, ages 4–53 years, were evaluated
over the course of a week-long admission at the NIH Clinical Research Center.
Four individuals were of the African American descent (4/31, 13%), 23/31 (74%)
were Caucasian, and 4/31 (13%) were Hispanic. Clinical data were further
enriched using selected results, such as genotype, obtained from outside
clinical records, or values from other NIH protocols (<ext-link ext-link-type="uri" xlink:href="https://ClinicalTrials.gov">ClinicalTrials.gov</ext-link> Identifiers: <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT00369421">NCT00369421</ext-link> and <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT01780168">NCT01780168</ext-link>) when subjects were
co-enrolled.</p>
              </sec>
              <sec id="S8">
                <title>Clinical and laboratory studies</title>
                <p id="P9">Testing related to renal function included the measurements of blood
pressure, serum creatinine, cystatin C, plasma bicarbonate, total serum calcium,
phosphorus, 25-OH-vitamin D, 1,25-OH-vitamin D, intact parathyroid hormone
(PTH), erythropoietin, and 24-hour creatinine clearance. Imaging included
abdominal ultrasound and transthoracic echocardiography. In pediatric patients
(ages &lt;19 years), eGFR was calculated using the updated creatinine-based
Schwartz bedside equation (2009)<sup><xref rid="R10" ref-type="bibr">10</xref></sup> and cystatin C-based Schwartz equation (2012).<sup><xref rid="R11" ref-type="bibr">11</xref></sup> In patients &gt;19 years
of age, eGFR was estimated using the Chronic Kidney Disease Epidemiology
Collaboration (CKD-EPI) Creatinine Equation (2009),<sup><xref rid="R12" ref-type="bibr">12</xref></sup> and the CKD-EPI Cystatin C Equation
(2012).<sup><xref rid="R13" ref-type="bibr">13</xref></sup></p>
              </sec>
              <sec id="S9">
                <title>Statistics</title>
                <p id="P10">Creatinine-based, and cystatin C-based methods of estimating GFR were
compared either using a paired t-test of the means after checking normality with
the D’Agostino-Pearson test or using linear regression fitting followed
by the slope and intercept comparisons. Kidney growth analysis in pediatric PA
patients was performed on the maximal renal length data, using a slope and
intercept comparison to a published reference group matched for age and sex
<sup><xref rid="R14" ref-type="bibr">14</xref></sup>. To compare daily
creatinine excretion among PA subjects, age-, height-, and sex-adjusted z-scores
were calculated using the means and standard deviations from published reference
populations.<sup><xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref></sup> A P value &lt;0.05 was
interpreted as statistically significant. Statistical analysis was performed
using GraphPad Prism 6 (GraphPad Software, La Jolla, CA).</p>
              </sec>
            </sec>
            <sec id="S10">
              <title>Results</title>
              <sec id="S11">
                <title>Patient Characteristics</title>
                <p id="P11">Selected clinical, genetic, and laboratory parameters are summarized in
<xref rid="T1" ref-type="table">Table 1</xref>. Among 31 participants, 55%
were female and 26% of the participants were older than 19 years of age.
Biallelic pathogenic variants were present in <italic>PCCA</italic> (13
subjects) and <italic>PCCB</italic> (17 subjects) (<xref rid="T1" ref-type="table">Table 1</xref>). In one participant, molecular confirmation
was not obtained. Three participants (3/31, 10%) had received a liver transplant
for metabolic instability - at ages 9, 13, and 35 months.</p>
              </sec>
              <sec id="S12">
                <title>Renal Indices</title>
                <p id="P12">The mean renal length in PA subjects, irrespective of the underlying
renal function estimates, was similar to the published control populations
(<xref rid="SD1" ref-type="supplementary-material">Supplemental Figures
1A</xref> and <xref rid="SD1" ref-type="supplementary-material">1B</xref>).
Three patients (10%) had simple renal cysts (<xref rid="SD2" ref-type="supplementary-material">Supplemental Figure 2</xref>). In this
cross-sectional cohort, the frequency of simple cysts was comparable to the
prevalence of simple renal cysts in the general population (10.7% in Chang et
al).<sup><xref rid="R17" ref-type="bibr">17</xref></sup> Low serum
phosphate was identified in 1/31 (3%), low 1,25-OH-vitamin D was present in 2/31
(6%), elevated intact PTH was present 3/31 (10%), elevated total serum calcium
was present in 3/31 (10%), low plasma bicarbonate was present in 10/31 (32%),
and a history of hypertension was present in 6/31 (19%) (<xref rid="T1" ref-type="table">Table 1</xref>). Nine of 31 participants were taking
β-blockers for cardiac indications and one participant was also taking an
angiotensin II receptor blocker for hypertension, which affected our ability to
assess whether hypertension was present at the time of evaluation. Transthoracic
echocardiogram revealed reduced left ventricular contractility in 4/31 patients
(13%). Erythropoietin was elevated in 7/27 subjects (26%) and correlated with
bone marrow suppression. Cross-sectional analysis of creatinine eGFR in
non-transplanted patients suggested an age-dependent pattern of renal function
decline (<xref rid="F1" ref-type="fig">Figure 1A</xref>, P value &lt;0.002,
<italic>r</italic> = −0.536). However, the cystatin C eGFR in
non-transplanted patients revealed that eGFR was reduced in in the first decade
of life and progressively declined in some subjects in adulthood (<xref rid="F1" ref-type="fig">Figure 1B</xref>). In pediatric patients, creatinine and
cystatin C eGFRs showed significant discrepancy (<xref rid="F1" ref-type="fig">Figure 1C</xref>, P value &lt;0.0001). In adults, the prevalence of an
eGFR &lt;60 mL/min/1.73 m<sup>2</sup> was 50% (4/8) by both the CKD-EPI
creatinine-based (2009) formula and the CKD-EPI cystatin C equation (2012)
(<xref rid="F1" ref-type="fig">Figure 1C</xref>). However, across all ages
and all CKD categories (stages G2-G4), creatinine eGFRs classified only 4/31
(13%) patients as having CKD, while the cystatin C eGFRs classified 25/30
patients (82%) to have an eGFR &lt;90 mL/min/1.73 m<sup>2</sup>
(Fisher’s exact test, P value &lt;0.0001). When we compared
regression lines of the creatinine eGFR and cystatin C eGFR in non-transplanted
patients (<xref rid="F1" ref-type="fig">Figure 1D</xref>), the Y-axis intercept
of the creatinine eGFR regression line was significantly higher than the
intercept for cystatin C eGFR (P value &lt; 0.0001) and the difference
between slopes approached statistical significance (P value = 0.0508).</p>
                <p id="P13">We reasoned that sources of discrepancy between the creatinine and
cystatin C eGFR in PA patients could be due to lower-than-average serum
creatinine concentrations resulting from either impaired growth, sarcopenia,
meat-restricted diets, reduced methionine intake, diminished synthesis of
creatine in the liver, and/or increased tubular secretion of creatinine.
Therefore, to explore potential relationships between these variables, we
performed linear regression analyses between serum creatinine or cystatin C,
using protein consumption, intake of protein equivalent from medical foods,
height, body mass index, and body composition measured by whole-body DEXA as
independent variables (<xref rid="SD4" ref-type="supplementary-material">Supplemental Table 1</xref>).</p>
                <p id="P14">Surprisingly, we found no association between serum creatinine and %
lean body mass or dietary composition and next evaluated daily creatinine
excretion adjusted for age, height, and sex.<sup><xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref></sup> The average
adjusted z-scores for 24-hour creatinine excretion were −0.536 in PA
girls (n=6) and −0.513 in PA boys (n=5) (<xref rid="SD5" ref-type="supplementary-material">Supplemental Table 2</xref>). One adult
male patient had a daily creatinine excretion z-score of −2.518. In adult
female patients, the daily average adjusted z-score of creatinine excretion was
−1.622 (n=5). The finding that PA patients have a below-average
creatinine excretion was corroborated by the high prevalence of elevated urinary
protein/creatinine ratio (13/21 patients, 62%). However, only 3 of 18 (17%)
patients showed minimal proteinuria on 24-hour urine protein analyses, and the
rest had normal protein excretion (<xref rid="SD3" ref-type="supplementary-material">Supplemental Figure 3</xref>). Lastly, we
performed an unbiased linear regression analysis between creatinine or cystatin
C and other clinical and laboratory parameters, which revealed associations with
parameters implicated in mechanisms of renal dysfunction including serum uric
acid, prealbumin, measured plasma osmolality, plasma lipocalin 2, intact
parathyroid hormone, total serum calcium, and left ventricular ejection fraction
(<xref rid="SD4" ref-type="supplementary-material">Supplemental Table
1</xref>).</p>
              </sec>
            </sec>
            <sec id="S13">
              <title>Discussion</title>
              <p id="P15">The improved ascertainment and survival of patients with PA over the last
several decades mandates recognition of long-term complications. Although recent
publications have suggested an association of CKD with propionic acidemia,<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R7" ref-type="bibr">7</xref></sup> the prevalence of
CKD has remained difficult to establish since reported data derive mainly from
either isolated case reports, small patient series, and registries. Therefore, we
sought to investigate renal disease in a study populated with a relatively large,
clinically diverse, and genetically heterogeneous cohort of PA patients that
included ~25% adults.</p>
              <p id="P16">Using the accepted definition of eGFR &lt;60 mL/min/1.73 m<sup>2</sup>,
we observed an unexpectedly high prevalence of CKD (50%) among adult PA patients.
While this value is lower than the nearly universal prevalence of CKD seen in
<italic>mut</italic><sup><italic>0</italic></sup> methylmalonic acidemia
patients,<sup><xref rid="R4" ref-type="bibr">4</xref></sup> it is higher
than what has been reported ( ~15%) in adult PA patients in the E-IMD
registry.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> After extending
our analyses to younger patients, we identified a significant discrepancy between
creatinine and cystatin C GFRs, with the bedside Schwartz creatinine-based equation
(2009) resulting in significantly higher GFR estimates compared to those generated
using the cystatin C-based equation. We hypothesized that higher creatinine GFR
estimates could be the result of lower serum creatinine levels driven by sarcopenia,
diet, or impaired creatine synthesis in the liver. While we did not observe an
association between the percent lean body weight and serum creatinine, we found that
PA patients had low adjusted daily creatinine excretion. Therefore, we suggest that
PA can lead to the reduction of whole-body creatine synthesis, which is likely the
result of a combination of dietary and metabolic influences. Several factors
inherent to organic acidemias, but known to affect whole-body creatine synthesis,
could lead to lower plasma creatinine, and thus bias GFR estimates. These could
include dietary restriction of methionine and branched-chain amino acids, reduced
intake of meats, low levels of physical activity, and/or impaired energy metabolism
in the liver and muscle arising from the mitochondrial dysfunction.<sup><xref rid="R18" ref-type="bibr">18</xref></sup></p>
              <p id="P17">The cellular mechanisms underlying the decline in renal function in
propionic acidemia have not been elucidated. While the evaluation of blood and
urinary parameters in our study did not reveal a specific pattern that would point
to a dominant mechanism(s) of injury (<xref rid="SD4" ref-type="supplementary-material">Supplemental Table 1</xref> and <xref rid="SD3" ref-type="supplementary-material">Supplemental Figure 3</xref>), our
observations are consistent with a single published case report describing
non-specific tubulointerstitial pathology and glomerular sclerosis.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> Likewise, the associations between
serum creatinine or cystatin C and plasma lipocalin-2, similar to MMA,<sup><xref rid="R19" ref-type="bibr">19</xref></sup> further suggest the role of
ongoing tubular injury in the etiology of CKD in PA.</p>
              <p id="P18">Without direct GFR measurements, this study cannot resolve the question
whether cystatin C eGFR is superior to creatinine eGFR to establish the diagnosis of
CKD. Although we did not measure eGFR using iothalamate or iohexol clearance, which,
unlike creatinine, are not affected by renal tubular secretion, the constellation of
laboratory and imaging studies featured in this paper clearly establish renal
insufficiency in many patients. The cross-sectional study design further limits our
ability to establish the progression of the renal disease, and a participation bias
may exist. Detailed protocol-based evaluations of all patients, irrespective of the
clinical suspicion of any organ system involvement, enabled observations of renal
complications and associated laboratory parameters. In particular, measurements of
cystatin C, plasma uric acid, 25-OH-vitamin D, 1,25-OH-vitamin D, PTH, plasma
osmolality, and 24-hour protein excretion in PA subjects suggest their usefulness as
part of CKD surveillance.</p>
              <p id="P19">The late recognition of kidney disease in PA can impede the initiation of
renal protective therapies aimed at delaying the onset or slowing the progression of
CKD, such as aggressive control of the acid/base status, control of blood pressure
through inhibition of renin-angiotensin system, and urate-lowering
therapy.<sup><xref rid="R20" ref-type="bibr">20</xref></sup> The diagnosis
of CKD might also inform decisions about the optimal timing for liver or combined
organ transplantation. Since PA patients have minimal hepatic capacity to metabolize
propionic acid, renal excretion is needed to clear “toxic”
metabolites, which, by virtue of increased concentrations in the setting of renal
insufficiency, might contribute to disease progression in other organ systems. For
example, whether worsening kidney disease has cardiac consequences seems possible,
given that we observed a strong negative correlation between the left ventricular
ejection fraction and renal indices in PA patients with CKD categories G3 and
G4.</p>
            </sec>
            <sec sec-type="supplementary-material" id="SM1">
              <title>Supplementary Material</title>
              <supplementary-material content-type="local-data" id="SD1">
                <label>Supplementary Figure 1</label>
                <media xlink:href="NIHMS1536028-supplement-Supp_Fig_1.pdf" orientation="portrait" xlink:type="simple" id="d36e523" position="anchor"/>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="SD2">
                <label>Supplementary Figure 2</label>
                <media xlink:href="NIHMS1536028-supplement-Supp_Fig_2.pdf" orientation="portrait" xlink:type="simple" id="d36e527" position="anchor"/>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="SD3">
                <label>Supplementary Figure 3</label>
                <media xlink:href="NIHMS1536028-supplement-Supp_Fig_3.pdf" orientation="portrait" xlink:type="simple" id="d36e531" position="anchor"/>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="SD4">
                <label>Supplementary Table 1</label>
                <media xlink:href="NIHMS1536028-supplement-Supp_Table_1__with_accepted_revisions_.docx" orientation="portrait" xlink:type="simple" id="d36e535" position="anchor"/>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="SD5">
                <label>Supplementary Table 2</label>
                <media xlink:href="NIHMS1536028-supplement-Supp_Table_2.docx" orientation="portrait" xlink:type="simple" id="d36e539" position="anchor"/>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="S14">
              <title>Acknowledgements</title>
              <p id="P20">We thank the patients, families, NIH Clinical Center clinical staff, and
referring healthcare providers for enabling this NIH natural history study. We thank
Julia Fekecs from NHGRI for help with medical illustrations and Niraj Triverdi
(NHGRI, NIH, Bethesda) for his guidance in designing statistical analysis. We thank
Qian (Katie) Sun from the Department of Laboratory Medicine at the NIH Clinical
Center for help with the <xref rid="S6" ref-type="sec">Methods and Materials</xref>
section of the manuscript. This work was supported by the Intramural Research
Programs of the National Human Genome Research Institute, the National Institute of
Diabetes and Digestive and Kidney Diseases, and the National Heart Lung and Blood
Institute.</p>
            </ack>
            <fn-group>
              <fn fn-type="COI-statement" id="FN1">
                <p id="P21">All the authors have declared no conflicts of interest relevant to this
work.</p>
              </fn>
              <fn id="FN2">
                <p id="P22"><bold>Disclosures</bold>: none</p>
              </fn>
            </fn-group>
            <ref-list>
              <title>References</title>
              <ref id="R1">
                <label>1.</label>
                <mixed-citation publication-type="book"><name><surname>Shchelochkov</surname><given-names>OA</given-names></name>, <name><surname>Carrillo</surname><given-names>N</given-names></name>, <name><surname>Venditti</surname><given-names>C</given-names></name>. <article-title>Propionic Acidemia</article-title>. In: <name><surname>Adam</surname><given-names>MP</given-names></name>, <name><surname>Ardinger</surname><given-names>HH</given-names></name>, <name><surname>Pagon</surname><given-names>RA</given-names></name>, <etal/>, eds. <source>GeneReviews((R))</source>. <publisher-loc>Seattle
(WA)</publisher-loc><year>1993</year>.</mixed-citation>
              </ref>
              <ref id="R2">
                <label>2.</label>
                <mixed-citation publication-type="journal"><name><surname>Kölker</surname><given-names>S</given-names></name>, <name><surname>Valayannopoulos</surname><given-names>V</given-names></name>, <name><surname>Burlina</surname><given-names>AB</given-names></name>, <etal/><article-title>The phenotypic spectrum of organic acidurias and urea cycle
disorders. Part 2: the evolving clinical phenotype</article-title>.
<source>Journal of Inherited Metabolic Disease</source>.
<year>2015</year>;<volume>38</volume>(<issue>6</issue>):<fpage>1059</fpage>–<lpage>1074</lpage>.<pub-id pub-id-type="pmid">25875216</pub-id></mixed-citation>
              </ref>
              <ref id="R3">
                <label>3.</label>
                <mixed-citation publication-type="journal"><name><surname>Horster</surname><given-names>F</given-names></name>, <name><surname>Baumgartner</surname><given-names>MR</given-names></name>, <name><surname>Viardot</surname><given-names>C</given-names></name>, <etal/><article-title>Long-term outcome in methylmalonic acidurias is influenced by the
underlying defect (mut0, mut-, cblA, cblB)</article-title>.
<source>Pediatric research</source>.
<year>2007</year>;<volume>62</volume>(<issue>2</issue>):<fpage>225</fpage>–<lpage>230</lpage>.<pub-id pub-id-type="pmid">17597648</pub-id></mixed-citation>
              </ref>
              <ref id="R4">
                <label>4.</label>
                <mixed-citation publication-type="journal"><name><surname>Kruszka</surname><given-names>PS</given-names></name>, <name><surname>Manoli</surname><given-names>I</given-names></name>, <name><surname>Sloan</surname><given-names>JL</given-names></name>, <name><surname>Kopp</surname><given-names>JB</given-names></name>, <name><surname>Venditti</surname><given-names>CP</given-names></name>. <article-title>Renal growth in isolated methylmalonic
acidemia</article-title>. <source>Genetics in medicine : official journal of
the American College of Medical Genetics</source>.
<year>2013</year>;<volume>15</volume>(<issue>12</issue>):<fpage>990</fpage>–<lpage>996</lpage>.<pub-id pub-id-type="pmid">23639900</pub-id></mixed-citation>
              </ref>
              <ref id="R5">
                <label>5.</label>
                <mixed-citation publication-type="journal"><name><surname>Lam</surname><given-names>C</given-names></name>, <name><surname>Desviat</surname><given-names>LR</given-names></name>, <name><surname>Perez-Cerda</surname><given-names>C</given-names></name>, <name><surname>Ugarte</surname><given-names>M</given-names></name>, <name><surname>Barshop</surname><given-names>BA</given-names></name>, <name><surname>Cederbaum</surname><given-names>S</given-names></name>. <article-title>45-Year-old female with propionic acidemia, renal
failure, and premature ovarian failure; late complications of propionic
acidemia?</article-title><source>Molecular genetics and metabolism</source>.
<year>2011</year>;<volume>103</volume>(<issue>4</issue>):<fpage>338</fpage>–<lpage>340</lpage>.<pub-id pub-id-type="pmid">21549625</pub-id></mixed-citation>
              </ref>
              <ref id="R6">
                <label>6.</label>
                <mixed-citation publication-type="journal"><name><surname>Lehnert</surname><given-names>W</given-names></name>, <name><surname>Sperl</surname><given-names>W</given-names></name>, <name><surname>Suormala</surname><given-names>T</given-names></name>, <name><surname>Baumgartner</surname><given-names>ER</given-names></name>. <article-title>Propionic acidaemia: clinical, biochemical and
therapeutic aspects</article-title>. <source>European Journal of
Pediatrics</source>.
<year>1994</year>;<volume>153</volume>(<issue>1</issue>):<fpage>S68</fpage>–<lpage>S80</lpage>.<pub-id pub-id-type="pmid">7957390</pub-id></mixed-citation>
              </ref>
              <ref id="R7">
                <label>7.</label>
                <mixed-citation publication-type="journal"><name><surname>Vernon</surname><given-names>HJ</given-names></name>, <name><surname>Bagnasco</surname><given-names>S</given-names></name>, <name><surname>Hamosh</surname><given-names>A</given-names></name>, <name><surname>Sperati</surname><given-names>CJ</given-names></name>. <article-title>Chronic kidney disease in an adult with propionic
acidemia</article-title>. <source>JIMD reports</source>.
<year>2014</year>;<volume>12</volume>:<fpage>5</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">23756992</pub-id></mixed-citation>
              </ref>
              <ref id="R8">
                <label>8.</label>
                <mixed-citation publication-type="journal"><name><surname>Charbit-Henrion</surname><given-names>F</given-names></name>, <name><surname>Lacaille</surname><given-names>F</given-names></name>, <name><surname>McKiernan</surname><given-names>P</given-names></name>, <etal/><article-title>Early and late complications after liver transplantation for
propionic acidemia in children: a two centers study</article-title>.
<source>American journal of transplantation : official journal of the
American Society of Transplantation and the American Society of Transplant
Surgeons</source>.
<year>2015</year>;<volume>15</volume>(<issue>3</issue>):<fpage>786</fpage>–<lpage>791</lpage>.</mixed-citation>
              </ref>
              <ref id="R9">
                <label>9.</label>
                <mixed-citation publication-type="journal"><name><surname>Quintero</surname><given-names>J</given-names></name>, <name><surname>Molera</surname><given-names>C</given-names></name>, <name><surname>Juamperez</surname><given-names>J</given-names></name>, <etal/><article-title>The role of liver transplantation in propionic
acidemia</article-title>. <source>Liver transplantation : official
publication of the American Association for the Study of Liver Diseases and
the International Liver Transplantation Society</source>.
<year>2018</year>.</mixed-citation>
              </ref>
              <ref id="R10">
                <label>10.</label>
                <mixed-citation publication-type="journal"><name><surname>Schwartz</surname><given-names>GJ</given-names></name>, <name><surname>Work</surname><given-names>DF</given-names></name>. <article-title>Measurement and estimation of GFR in children and
adolescents</article-title>. <source>Clinical journal of the American
Society of Nephrology : CJASN</source>.
<year>2009</year>;<volume>4</volume>(<issue>11</issue>):<fpage>1832</fpage>–<lpage>1843</lpage>.<pub-id pub-id-type="pmid">19820136</pub-id></mixed-citation>
              </ref>
              <ref id="R11">
                <label>11.</label>
                <mixed-citation publication-type="journal"><name><surname>Schwartz</surname><given-names>GJ</given-names></name>, <name><surname>Schneider</surname><given-names>MF</given-names></name>, <name><surname>Maier</surname><given-names>PS</given-names></name>, <etal/><article-title>Improved equations estimating GFR in children with chronic kidney
disease using an immunonephelometric determination of cystatin
C</article-title>. <source>Kidney international</source>.
<year>2012</year>;<volume>82</volume>(<issue>4</issue>):<fpage>445</fpage>–<lpage>453</lpage>.<pub-id pub-id-type="pmid">22622496</pub-id></mixed-citation>
              </ref>
              <ref id="R12">
                <label>12.</label>
                <mixed-citation publication-type="journal"><name><surname>Levey</surname><given-names>AS</given-names></name>, <name><surname>Stevens</surname><given-names>LA</given-names></name>, <name><surname>Schmid</surname><given-names>CH</given-names></name>, <etal/><article-title>A new equation to estimate glomerular filtration
rate</article-title>. <source>Annals of internal medicine</source>.
<year>2009</year>;<volume>150</volume>(<issue>9</issue>):<fpage>604</fpage>–<lpage>612</lpage>.<pub-id pub-id-type="pmid">19414839</pub-id></mixed-citation>
              </ref>
              <ref id="R13">
                <label>13.</label>
                <mixed-citation publication-type="journal"><name><surname>Inker</surname><given-names>LA</given-names></name>, <name><surname>Schmid</surname><given-names>CH</given-names></name>, <name><surname>Tighiouart</surname><given-names>H</given-names></name>, <etal/><article-title>Estimating Glomerular Filtration Rate from Serum Creatinine and
Cystatin C</article-title>. <source>New England Journal of
Medicine</source>.
<year>2012</year>;<volume>367</volume>(<issue>1</issue>):<fpage>20</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="pmid">22762315</pub-id></mixed-citation>
              </ref>
              <ref id="R14">
                <label>14.</label>
                <mixed-citation publication-type="journal"><name><surname>Rosenbaum</surname><given-names>DM</given-names></name>, <name><surname>Korngold</surname><given-names>E</given-names></name>, <name><surname>Teele</surname><given-names>RL</given-names></name>. <article-title>Sonographic assessment of renal length in normal
children</article-title>. <source>AJR American journal of
roentgenology</source>.
<year>1984</year>;<volume>142</volume>(<issue>3</issue>):<fpage>467</fpage>–<lpage>469</lpage>.<pub-id pub-id-type="pmid">6607625</pub-id></mixed-citation>
              </ref>
              <ref id="R15">
                <label>15.</label>
                <mixed-citation publication-type="journal"><name><surname>Johner</surname><given-names>SA</given-names></name>, <name><surname>Boeing</surname><given-names>H</given-names></name>, <name><surname>Thamm</surname><given-names>M</given-names></name>, <name><surname>Remer</surname><given-names>T</given-names></name>. <article-title>Urinary 24-h creatinine excretion in adults and its use
as a simple tool for the estimation of daily urinary analyte excretion from
analyte/creatinine ratios in populations</article-title>. <source>European
Journal Of Clinical Nutrition</source>.
<year>2015</year>;<volume>69</volume>:<fpage>1336</fpage>.<pub-id pub-id-type="pmid">26220572</pub-id></mixed-citation>
              </ref>
              <ref id="R16">
                <label>16.</label>
                <mixed-citation publication-type="journal"><name><surname>Remer</surname><given-names>T</given-names></name>, <name><surname>Neubert</surname><given-names>A</given-names></name>, <name><surname>Maser-Gluth</surname><given-names>C</given-names></name>. <article-title>Anthropometry-based reference values for 24-h urinary
creatinine excretion during growth and their use in endocrine and
nutritional research</article-title>. <source>The American Journal of
Clinical Nutrition</source>.
<year>2002</year>;<volume>75</volume>(<issue>3</issue>):<fpage>561</fpage>–<lpage>569</lpage>.<pub-id pub-id-type="pmid">11864864</pub-id></mixed-citation>
              </ref>
              <ref id="R17">
                <label>17.</label>
                <mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>CC</given-names></name>, <name><surname>Kuo</surname><given-names>JY</given-names></name>, <name><surname>Chan</surname><given-names>WL</given-names></name>, <name><surname>Chen</surname><given-names>KK</given-names></name>, <name><surname>Chang</surname><given-names>LS</given-names></name>. <article-title>Prevalence and clinical characteristics of simple renal
cyst</article-title>. <source>Journal of the Chinese Medical Association :
JCMA</source>.
<year>2007</year>;<volume>70</volume>(<issue>11</issue>):<fpage>486</fpage>–<lpage>491</lpage>.<pub-id pub-id-type="pmid">18063502</pub-id></mixed-citation>
              </ref>
              <ref id="R18">
                <label>18.</label>
                <mixed-citation publication-type="journal"><name><surname>Chandler</surname><given-names>RJ</given-names></name>, <name><surname>Zerfas</surname><given-names>PM</given-names></name>, <name><surname>Shanske</surname><given-names>S</given-names></name>, <etal/><article-title>Mitochondrial dysfunction in mut methylmalonic
acidemia</article-title>. <source>FASEB journal : official publication of
the Federation of American Societies for Experimental Biology</source>.
<year>2009</year>;<volume>23</volume>(<issue>4</issue>):<fpage>1252</fpage>–<lpage>1261</lpage>.<pub-id pub-id-type="pmid">19088183</pub-id></mixed-citation>
              </ref>
              <ref id="R19">
                <label>19.</label>
                <mixed-citation publication-type="journal"><name><surname>Manoli</surname><given-names>I</given-names></name>, <name><surname>Sysol</surname><given-names>JR</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>, <etal/><article-title>Targeting proximal tubule mitochondrial dysfunction attenuates
the renal disease of methylmalonic acidemia</article-title>.
<source>Proceedings of the National Academy of Sciences of the United States
of America</source>.
<year>2013</year>;<volume>110</volume>(<issue>33</issue>):<fpage>13552</fpage>–<lpage>13557</lpage>.<pub-id pub-id-type="pmid">23898205</pub-id></mixed-citation>
              </ref>
              <ref id="R20">
                <label>20.</label>
                <mixed-citation publication-type="journal"><name><surname>Ward</surname><given-names>F</given-names></name>, <name><surname>Holian</surname><given-names>J</given-names></name>, <name><surname>Murray</surname><given-names>PT</given-names></name>. <article-title>Drug therapies to delay the progression of chronic
kidney disease</article-title>. <source>Clinical medicine (London,
England)</source>.
<year>2015</year>;<volume>15</volume>(<issue>6</issue>):<fpage>550</fpage>–<lpage>557</lpage>.</mixed-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig id="F1" orientation="portrait" position="float">
              <label>Figure 1.</label>
              <caption>
                <title>Significant discrepancy between the creatinine and cystatin C GFR estimates
and select laboratory parameters associated with declining eGFR.</title>
                <p id="P23"><bold>A</bold>. Cross-sectional analysis of creatinine eGFR in
non-transplanted patients suggested an age-dependent trend of renal function
decline (P value &lt;0.002, <italic>r</italic> = −0.536). G2, G3 and
G4–5 denotes levels of renal function based on eGFR. <bold>B.</bold>
Cystatin C eGFR in non-transplanted patients suggested the eGFR was reduced in
early childhood, with progressive decline in some subjects in the late teen-age
or early adult years; 25/30 subjects (82%) had eGFR &lt;90 mL/min/1.73
m<sup>2</sup> (chronic kidney disease stages 2–4). <bold>C.</bold>
Creatinine (Cr eGFR) and cystatin C eGFRs (CysC eGFR) showed significant
disagreement (P value &lt;0.0001). <bold>D.</bold> Linear regression of
creatinine eGFR and cystatin C eGFR in non-transplanted patients demonstrated
that the intercept of the creatinine eGFR was significantly different from
cystatin C eGFR (P value &lt; 0.0001, denoted by the # sign).
<bold>E</bold>. Plasma lipocalin-2, a biomarker of tubular injury, was
associated with the cystatin C eGFR (P value &lt;0.0001, <italic>r</italic>
= − 0.717). <bold>F</bold>. Plasma uric acid, a factor that can be
associated with CKD, rises with decreasing cystatin C eGFR (P value
&lt;0.0001, <italic>r</italic> = −0.718). Dotted lines in
<bold>Figures 1A, 1B, 1E,</bold> and <bold>1F</bold> represent 95%
prediction bands.</p>
              </caption>
              <graphic xlink:href="nihms-1536028-f0001"/>
            </fig>
            <table-wrap id="T1" position="float" orientation="landscape">
              <?scale 70?>
              <?legal?>
              <label>Table 1.</label>
              <caption>
                <p id="P24">Demographics, Genetics, and Renal-Related Findings in the NIH Propionic
Acidemia Cohort.</p>
              </caption>
              <table frame="box" rules="all">
                <colgroup span="1">
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="center" valign="top" rowspan="1" colspan="1">Age of Visit, (years)</th>
                    <th align="center" valign="top" rowspan="1" colspan="1">Gene</th>
                    <th align="center" valign="top" rowspan="1" colspan="1">Transplant Status</th>
                    <th align="center" valign="top" rowspan="1" colspan="1">Variant 1 (cDNA)</th>
                    <th align="center" valign="top" rowspan="1" colspan="1">Variant 1 (protein)</th>
                    <th align="center" valign="top" rowspan="1" colspan="1">Variant 2 (cDNA)</th>
                    <th align="center" valign="top" rowspan="1" colspan="1">Variant 2 (protein)</th>
                    <th align="center" valign="top" rowspan="1" colspan="1">Crt eGFR</th>
                    <th align="center" valign="top" rowspan="1" colspan="1">CysC eGFR</th>
                    <th align="center" valign="top" rowspan="1" colspan="1">Renal-Related Manifestations</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">4</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCA</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">LT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1288C&gt;T</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Arg430Ter</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.776T&gt;G</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Leu259Arg</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">142</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">67</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">↑EPO</td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">6</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCA</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c. 1284+1G&gt;A</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Canonical Splice</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1684T&gt;C</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Ser562Pro</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">133</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">79</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">6</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCA</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">LT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.782A&gt;G</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Glu261Gly</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.923dupT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Leu308Phefs*35</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">121</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">59</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">↓HCO<sub>3</sub></td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">8</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCA</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c. 1284+1G&gt;A</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Canonical Splice</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1684T&gt;C</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Ser562Pro</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">140</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">86</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">10</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCA</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.742G&gt;A</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Glu248Lys</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1430G&gt;T</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Val478_Gly514del<sup><xref rid="TFN2" ref-type="table-fn">1</xref></sup></td>
                    <td align="center" valign="top" rowspan="1" colspan="1">147</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">78</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">HT, ↓HCO<sub>3</sub></td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">10</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCA</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.802C&gt;T</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Arg268Cys</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1899+4_1899+7delAGTA</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p. p.Cys616_Val633del<sup><xref rid="TFN3" ref-type="table-fn">2</xref></sup></td>
                    <td align="center" valign="top" rowspan="1" colspan="1">169</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">97</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">11</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCA</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Deletion of exons 23 and 24</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">n.a.</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Deletion of exons 23 and 24</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">n.a.</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">102</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">73</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">↓vitD, ↑EPO</td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">12</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCA</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.893A&gt;G</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Lys298Arg</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Deletion of exons 13–20</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">n.a.</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">115</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">70</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">12</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCA</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1284+1G&gt;A</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Canonical Splice</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.2027del</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Lys676Serfs*6</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">171</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">90</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">↑EPO, ↓HCO<sub>3</sub></td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">14</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCA</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.722delG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Gly241Valfs*19</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.722delG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Gly241Valfs*19</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">195</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">n.a.</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">16</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCA</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1268C&gt;T</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Pro423Leu</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1899+4_1899+7delAGTA</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p. p.Cys616_Val633del<sup><xref rid="TFN3" ref-type="table-fn">2</xref></sup></td>
                    <td align="center" valign="top" rowspan="1" colspan="1">127</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">86</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">34</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCA</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.600+1G&gt;A</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Canonical Splice</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.2119–9A&gt;G</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Intronic</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">40</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">35</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">↑PTH, ↓HCO<sub>3</sub>,
↓LVEF</td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">37</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCA</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1572_1573delGT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Gln524Hisfs*29</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.434T&gt;C</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Phe145Ser</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">136</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">105</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">↓HCO<sub>3</sub></td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">5</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCB</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.683C&gt;T</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Pro228Leu</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1218_1231del14ins12</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Gly407Argfs*14</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">152</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">88</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">↓HCO<sub>3</sub></td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">5</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCB</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.764–2delA</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Canonical Splice</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.975_977delTGA</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Asp325del</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">179</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">67</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">5</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCB</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.386_387delTTinsAAC</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Phe129Ter</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1606A&gt;G</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Asn536Asp</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">134</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">77</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">↑Phos, ↓HCO<sub>3</sub></td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">5</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCB</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.764–2delA</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Canonical Splice</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.975_977delTGA</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Asp325del</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">144</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">67</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">HT</td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">6</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCB</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.683C&gt;T</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Pro228Leu</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1218_1231del14ins12</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Gly407ArgfsX14</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">129</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">68</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">6</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCB</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">LT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1259_1260insT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Glu421Ter</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1259_1260insT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Glu421Ter</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">115</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">71</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">HT, ↓HCO<sub>3</sub></td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">8</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCB</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.337C&gt;T</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Arg113Ter</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1275_1227delATC</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Ile409del</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">128</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">87</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">↑EPO</td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">14</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCB</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.386_387delTTinsAAC</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Phe129Ter</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1552delG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Asp518Thrfs*33</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">134</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">84</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">↓HCO<sub>3</sub></td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">16</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCB</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1172_1173delTT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Phe391Cysfs*2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1172_1173delTT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Phe391Cysfs*2</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">109</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">68</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">17</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCB</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1218_1231del14ins12</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Gly407Argfs*14</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1218_1231del14ins12</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Gly407Argfs*14</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">111</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">75</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">↑EPO</td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">17</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCB</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1218_1231del14ins12</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Gly407Argfs*14</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.990dupT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Glu331Ter</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">131</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">103</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">HT, ↑EPO</td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">19</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCB</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1204delG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Ala402Hisfs*41</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.335G&gt;A</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Gly112Asp</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">55</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">33</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">HT, ↓vitD, ↑Ca</td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">24</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCB</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">TBD</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">TBD</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">TBD</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">TBD</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">23</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">25</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">↑PTH, ↑Ca,
↓HCO<sub>3</sub>, ↓LVEF</td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">26</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCA</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.716+5G&gt;C</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Intronic</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.782A&gt;G</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Glu261Gly</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">129</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">100</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">↓LVEF</td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">28</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCB</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.734G&gt;A</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Gly245Asp</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Deletion of exon 9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">n.a.</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">99</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">65</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">28</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCB</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1218_1231del14ins12</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Gly407Argfs*14</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1495C&gt;T</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Arg499Ter</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">96</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">58</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">53</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">
                      <italic>PCCB</italic>
                    </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">KT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1142dupG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Cys381Trpfs*2 </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">c.1606A&gt;G</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">p.Asn536Asp </td>
                    <td align="center" valign="top" rowspan="1" colspan="1">55</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">53</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">HT, ↑PTH, ↑Ca, ↑EPO</td>
                  </tr>
                  <tr>
                    <td align="center" valign="top" rowspan="1" colspan="1">6</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">TBD</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">NT</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">TBD</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">TBD</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">TBD</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">TBD</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">97</td>
                    <td align="center" valign="top" rowspan="1" colspan="1">80</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">↓LVEF</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN1">
                  <p id="P25">Abbreviations (in the alphabetical order): ↑Ca –
elevated high total serum Ca; cDNA – coding DNA; Crt eGFR –
creatinine eGFR expressed in mL/min/1.73 m<sup>2</sup>; CysC eGFR –
cystatin C eGFR expressed in mL/min/1.73 m<sup>2</sup>; ↑EPO –
elevated plasma erythropoietin; ↓HCO<sub>3</sub> – low plasma
bicarbonate; HT – hypertension; KT – kidney transplant; LT
– liver transplant; ↓LVEF – low left ventricular
ejection fraction; n.a. – not available; NT –
not-transplanted; ↑Phos – elevated serum phosphorus;
↑PTH – elevated intact parathyroid hormone; TBD – to be
determined; ↓vitD – low 1,25-OH-vitamin D.</p>
                </fn>
                <fn id="TFN2">
                  <label>1</label>
                  <p id="P26">This variant most likely results in exon 17 skipping.</p>
                </fn>
                <fn id="TFN3">
                  <label>2</label>
                  <p id="P27">This variant most likely results in exon 21 skipping.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
